Monthly Archives: March 2015

Read and Watch #CancerFilm: The Emperor of All Maladies!

Posted on by

On March 30, PBS will begin airing the long-awaited Ken Burns film Cancer: The Emperor of All Maladies (#CancerFilm), which features several MSK clinical leaders and staff.

READ Dr. Siddhartha Mukherjee’s The Emperor of All Maladies: Biography of Cancer available now at the MSK Library. You’ll find this title in TriCat, our library catalog.

WATCH MSK’s Dr. Clifford A. Hudis, MD, chief of the Breast Cancer Medicine Service, speak with Dr. Mukherjee about his work and the upcoming documentary:
http://www.medscape.com/viewarticle/841334

TUNE IN on Monday, March 30 to your local PBS station to see Cancer: The Emperor of All Maladies. Learn more at www.cancerfilms.org

Got a Research Question?

Posted on by

If you have a question about your research, we’re here to help.  These fish know that there are lots of ways to get in touch with the library staff and get on with your day. Start here and let us point you in the right direction to get you going!

State of Cancer Care in the US and More….

Posted on by

Here are a few highlights of cancer research news that have recently caught my attention:

  • State of Cancer Care in America: 2015 Report Released by the American Society of Clinical Oncology

  • While there have been numerous studies on cancer survival outcomes of non-Hispanic whites and African-Americans, very little has been known about cancer survival outcomes for Asian-Americans, until now. A recent study conducted by researchers at Brigham and Women’s Hospital provides new insights into survival outcomes of Asian-Americans diagnosed with cancer. Read more on this study in the Journal of the National Cancer Institute.
  • Text messaging could help boost breast cancer screening according to a study conducted in the UK. A randomized control trial was carried out and it included 2,240 women. Results were published in the British Journal of Cancer.

Please feel free to contact Marisol Hernandez to share any comments.